Login
Please select your location and reference genome:
America - GRCh37 America - GRCh38 Europe, Middle East, Africa - GRCh37 Europe, Middle East, Africa - GRCh38
Select your region
Please select your preferred region, either the global region for international content or the United States region.

Congenica Inherited Cancer

Inherited Cancers

While most cancers develop spontaneously, around 5% of cancer diagnoses are linked to certain genetic markers that are passed down generations. Harbouring any of these variations doesn't automatically mean that an individual develops cancer, however, it certainly puts this person at greater risk.

Cancer types typically associated with inherited variants

  • Breast Cancer (BRCA1, BRCA2, PALB2)

  • Ovarian Cancer (BRCA1, BRCA2)

  • Pancreatic Cancer (BRCA1, BRCA2)

  • Prostate Cancer (BRCA1, BRCA2)

  • Li-Fraumeni Syndrome (TP53)

  • Hereditary non polyposis colon cancer/Lynch Syndrome (MLH1, MSH2, MSH6, PMS2)

  • Hamartoma Tumour Syndrome (PTEN)

  • Familial adenomatous polyposis (APC)

  • MUTYH associated polyposis (MUTYH)

  • Peutz Jeghers Syndrome (STK11)

  • Juvenile Polyposis Syndrome (SMAD4, BMPR1A)

  • Von Hippel Lindau Syndrome (VHL)

  • Tuberous sclerosis (TSC1, TSC2)

  • Birt-Hogg-Dube Syndrome (FLCN)

  • Multiple endocrine neoplasia type 1 and 2 (RET)

  • Retinoblastoma (RB1)

  • Familial Atypical Multiple Mole Melanoma Syndrome (CDKN2A)

  • Hereditary papillary cancer (MET, FH)

Identifying causative variants helps patient management, ensures potential tumours are detected as early as possible, provides options for preventative treatments and helps understand the implications for family members.

 

With our scalable, automated and cost-effective diagnostic platform Congenica is ideally placed to rapidly provide life-changing answers to patients and their families.
icon TAT light blue

Rapid turnaround time

Automated processes for fast and accurate decision-making supported by machine learning and AI

icon target light blue

Increased diagnostic yield

Increased diagnostic yield through automated variant prioritisation and expertly curated reference databases

icon quality light blue-1

CE-IVD certified

Validated, accurate and secure platform for high confidence in diagnostic outcome

icon flexibility light blue

Ultimate flexibility

From gene panels to whole genomes, SaaS or on premise, we offer ultimate flexibility to support all customer needs

Like to find out more or schedule a demo?

CONTACT US TODAY